Ozempic, Wegovy, and other GLP-1 drugs can be extremely beneficial for those looking to control their blood sugar levels or weight
By addressing the underlying metabolic, hormonal, and lifestyle factors, patients can achieve meaningful, lasting results with the right guidance
Potential Applications : BPC-157 shows potential applications in conditions such as Irritable Bowel Syndrome (IBS) and Crohns disease by supporting intestinal repair, reducing inflammation, and improving gut barrier integrity
NICE guidance (NG28) for type 2 diabetes management emphasises individualised nutritional approaches that promote sustainable healthy eating rather than restrictive diets
It represents one of the more established secretagogues in the compounding pharmacy space with a clearer regulatory pathway
- [Stability of GLP-1 Receptor Agonist Peptide Formulations Under Refrigerated Conditions]( *International Journal of Pharmaceutical Compounding*, 2022